Form 4: Definitive Healthcare Executive's Tax-Related Stock Sale

Sentiment:

Insider Transaction Report


Definitive Healthcare's Executive Chairman, Jason Krantz, disposed of 44,545 shares to cover tax obligations from restricted stock unit vesting.

Summary

  • Jason Ronald Krantz, Executive Chairman, Director, and 10% Owner of Definitive Healthcare Corp. (DH), reported a transaction.
  • The transaction involved the disposition of 44,545 shares of Class A Common Stock.
  • The shares were withheld by the Issuer to satisfy tax withholding obligations related to the vesting and settlement of previously reported restricted stock units.
  • The transaction occurred on February 1, 2026, at a price of $2.32 per share.
  • Following the transaction, Mr. Krantz directly beneficially owns 1,016,039 shares of Class A Common Stock.
  • Additionally, 450,000 shares are indirectly beneficially owned in trust by DH Holdings (f/k/a Jason R. Krantz 2009 Trust), of which Mr. Krantz is the beneficiary.
  • The transaction was made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. The transaction is a non-discretionary sale to cover tax obligations from RSU vesting, which is a standard practice and does not reflect a discretionary decision by the insider to sell shares based on company outlook.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction, as it is a report of an insider transaction.

Industry Context

StockSavvy.ai notes that Form 4 filings are routine disclosures of insider transactions, providing transparency into executive stock movements. This specific transaction, a tax-related sale to cover restricted stock unit vesting, is a common and non-discretionary event for executives and is generally not indicative of a change in management's sentiment towards the company's prospects.

Stakeholder Impact

  • Shareholders: Minimal direct impact, as this is a routine, non-discretionary transaction for tax purposes and does not signal a change in company fundamentals or insider confidence.

Key Dates

DateDescription
02/01/2026Date of transaction (disposition of shares for tax withholding).
02/03/2026Date the Form 4 was signed by Jonathan Paris, Attorney-in-Fact.

Recommendation

hold

This Form 4 reports a routine, non-discretionary sale of shares by an insider to cover tax obligations related to the vesting of restricted stock units. Such transactions are common and typically do not signal a change in the insider's view of the company's prospects or warrant a change in investment recommendation. Therefore, a 'hold' recommendation is appropriate as this event does not alter the fundamental investment thesis.

Keywords

Definitive Healthcare, DH, Jason Krantz, Form 4, insider transaction, stock sale, RSU, tax withholding, corporate governance

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.